Detalhe da pesquisa
1.
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer.
Oncologist;
27(9): 732-739, 2022 09 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35598202
2.
Association and interplay of surgeon and hospital volume with mortality after open abdominal aortic aneurysm repair in the modern era.
J Vasc Surg;
73(5): 1593-1602.e7, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32976969
3.
Functional Dependence and Mortality in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).
Am J Kidney Dis;
67(2): 283-92, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26612280
4.
Multi-state survival models with treatment effects and biomarkers: Simulations for study design assessment.
Cancer Epidemiol;
81: 102272, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36219984
5.
Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy.
NPJ Precis Oncol;
6(1): 44, 2022 Jun 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35739333
6.
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response.
Cancer Discov;
11(2): 282-292, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33127846
7.
Evidence-Based Development and Clinical Use of Precision Oncology Therapeutics.
Clin Pharmacol Ther;
108(3): 440-443, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32744335